Feasibility and Success Trial of Remote Patient Monitoring in Heart Failure
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- Saint Luke's Health System
- Study ID
- NCT05900362
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- VitalCare Platform — DEVICEAll participants will receive an VitalCare platform with tablet, Eko Duo with capability to record heart/lung sounds, blood pressure cuff, pulse oximetry and digital scale
Study Details
Previous research has investigated the use of remote patient monitoring in various clinical contexts, however there has not been a clinical trial examining use of the VitalCare platform for ambulatory management of heart failure. This trial will serve as a pilot study examining the feasibility of use of the VitalCare platform for ambulatory heart failure management and examine the effect of remote patient monitoring on patient engagement. To the investigators' knowledge, this will be the first study examining the effect of remote patient monitoring with the VitalCare platform on heart failure clinical outcomes, such as hospitalization for heart failure exacerbations and emergency room visits for heart failure.
Key Dates
- Start date
- Aug 1, 2024
- Status verified
- Jun 2024
- Primary completion
- Dec 31, 2025
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: InterventionalAll patients receive the VitalCare platform with a tablet computer, an Eko Duo device, a weight scale, a blood pressure cuff, a pulse oximeter
Primary Outcome Measure
Compliance with monitoring protocol [ Time Frame: 6 month ]
Central Contacts
- Sanjaya Gupta, MD8169311883
- Valerie Rader, MD8169311883
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Saint Luke's Hospital of Kansas City | Kansas City | Kansas | 64111 | Sanjaya Gupta, MD Sanjaya Gupta, MD (PRINCIPAL_INVESTIGATOR) |
| Saint Luke's South Hospital | Overland Park | Kansas | 66213 | Sanjaya Gupta, MD (PRINCIPAL_INVESTIGATOR) |
| Saint Luke's North Hospital | Kansas City | Missouri | 64154 | Sanjaya Gupta, MD (PRINCIPAL_INVESTIGATOR) |
| Saint Luke's East Hospital | Lee's Summit | Missouri | 64086 | Sanjaya Gupta, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Kansas City, KS
Related Studies
- Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection FractionPHASE1/PHASE2 · Recruiting · Sardocor Corp. · San Diego, California
- Circulating Markers for Ischemic Heart DiseaseRecruiting · UConn Health · Farmington, Connecticut
- Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart DiseaseRecruiting · University of Utah · Murray, Utah
- Stress and Congestive Heart FailureRecruiting · Yale University · Hartford, Connecticut